We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

1 hedge funds and large institutions have $312K invested in Redhill Biopharma in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $281K → $312K (+$31K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$311K – – –
U
2
UBS
Switzerland
$1K – – –
TRCT
3
Tower Research Capital (TRC)
New York
– -$3K – –

RDHL Hedge Fund Activity: Q3 2013 in Review

1 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2013, worth a combined $312K — up 11% from $281K a quarter earlier.

Fund positioning in RDHL was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Tower Research Capital (TRC), cutting an estimated $3K.

  • 1 institutional investor held Redhill Biopharma (RDHL) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $312K of Redhill Biopharma stock for Q3 2013, up 11% quarter-over-quarter.
  • 0 funds opened new Redhill Biopharma positions in Q3 2013 and 0 closed out.
  • The largest Redhill Biopharma seller in Q3 2013 was Tower Research Capital (TRC), an estimated $3K sold.

Based on aggregated 13F filings for Q3 2013.